Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | AUPH |
---|---|---|
09:32 ET | 33089 | 5.0201 |
09:34 ET | 3800 | 4.99 |
09:36 ET | 4722 | 5.0101 |
09:38 ET | 2193 | 5 |
09:41 ET | 6765 | 5.0099 |
09:43 ET | 7005 | 5.0001 |
09:45 ET | 1283 | 5 |
09:48 ET | 14234 | 5.02 |
09:50 ET | 2800 | 5 |
09:52 ET | 1000 | 4.9901 |
09:54 ET | 2214 | 4.995 |
09:56 ET | 9987 | 4.99 |
09:57 ET | 1214 | 4.995 |
09:59 ET | 896 | 4.995 |
10:01 ET | 9318 | 5 |
10:03 ET | 989 | 5.005 |
10:06 ET | 7935 | 5 |
10:08 ET | 700 | 4.995 |
10:10 ET | 11945 | 4.985 |
10:12 ET | 22325 | 5.005 |
10:14 ET | 300 | 5 |
10:15 ET | 22615 | 5.01 |
10:19 ET | 11478 | 4.995 |
10:21 ET | 867 | 4.995 |
10:24 ET | 5666 | 5 |
10:26 ET | 9674 | 5.02 |
10:28 ET | 5803 | 5.0199 |
10:30 ET | 500 | 5.015 |
10:32 ET | 200 | 5.015 |
10:33 ET | 814 | 5.01 |
10:35 ET | 30550 | 5.025 |
10:37 ET | 6552 | 5.015 |
10:39 ET | 1100 | 5.015 |
10:42 ET | 1500 | 5.015 |
10:44 ET | 300 | 5.015 |
10:46 ET | 1132 | 5.015 |
10:48 ET | 646 | 5.015 |
10:50 ET | 500 | 5.01 |
10:51 ET | 3236 | 5.015 |
10:53 ET | 14598 | 5.02 |
10:55 ET | 2300 | 5.025 |
10:57 ET | 300 | 5.02 |
11:00 ET | 4999 | 5.02 |
11:02 ET | 2876 | 5.01 |
11:04 ET | 400 | 5.015 |
11:06 ET | 950 | 5.015 |
11:08 ET | 2977 | 5.01 |
11:09 ET | 1318 | 5.01 |
11:11 ET | 600 | 5.01 |
11:13 ET | 700 | 5.01 |
11:15 ET | 1184 | 5.01 |
11:18 ET | 6495 | 5.02 |
11:20 ET | 100 | 5.025 |
11:22 ET | 488 | 5.02 |
11:24 ET | 1200 | 5.025 |
11:26 ET | 12346 | 5.03 |
11:27 ET | 7000 | 5.03 |
11:29 ET | 13375 | 5.03 |
11:31 ET | 1130 | 5.04 |
11:33 ET | 1009 | 5.035 |
11:36 ET | 4500 | 5.04 |
11:38 ET | 1900 | 5.035 |
11:40 ET | 622 | 5.035 |
11:42 ET | 3875 | 5.035 |
11:44 ET | 100 | 5.03 |
11:45 ET | 6620 | 5.025 |
11:47 ET | 647 | 5.03 |
11:49 ET | 1100 | 5.03 |
11:51 ET | 1550 | 5.025 |
11:54 ET | 350 | 5.03 |
11:56 ET | 12881 | 5.03 |
11:58 ET | 10200 | 5.02 |
12:00 ET | 300 | 5.025 |
12:02 ET | 800 | 5.03 |
12:03 ET | 4852 | 5.022 |
12:05 ET | 400 | 5.025 |
12:07 ET | 2201 | 5.025 |
12:09 ET | 16007 | 5.015 |
12:12 ET | 300 | 5.015 |
12:14 ET | 727 | 5.015 |
12:16 ET | 17137 | 5 |
12:18 ET | 11485 | 5.015 |
12:20 ET | 700 | 5.015 |
12:21 ET | 200 | 5.01 |
12:23 ET | 100 | 5.01 |
12:25 ET | 500 | 5.015 |
12:27 ET | 6152 | 5.0107 |
12:30 ET | 2100 | 5.01 |
12:32 ET | 3600 | 5.005 |
12:34 ET | 1100 | 5.005 |
12:36 ET | 4861 | 4.995 |
12:38 ET | 1100 | 4.9999 |
12:39 ET | 1491 | 4.9901 |
12:41 ET | 14530 | 4.99 |
12:43 ET | 7516 | 4.99 |
12:45 ET | 1352 | 4.99 |
12:48 ET | 3059 | 4.995 |
12:50 ET | 7929 | 4.985 |
12:52 ET | 9706 | 4.9999 |
12:54 ET | 1270 | 4.995 |
12:56 ET | 179 | 4.995 |
12:59 ET | 300 | 4.99 |
01:03 ET | 8972 | 4.99 |
01:06 ET | 9894 | 4.995 |
01:08 ET | 1203 | 4.995 |
01:10 ET | 950 | 4.995 |
01:12 ET | 651 | 4.9931 |
01:14 ET | 1800 | 4.9901 |
01:15 ET | 2368 | 5 |
01:17 ET | 2720 | 4.99 |
01:19 ET | 21826 | 4.985 |
01:21 ET | 6666 | 4.9763 |
01:24 ET | 14107 | 4.97 |
01:26 ET | 100 | 4.97 |
01:28 ET | 14512 | 4.97 |
01:30 ET | 970 | 4.975 |
01:32 ET | 1974 | 4.97 |
01:33 ET | 200 | 4.97 |
01:35 ET | 1151 | 4.975 |
01:39 ET | 100 | 4.97 |
01:42 ET | 800 | 4.97 |
01:44 ET | 1000 | 4.97 |
01:48 ET | 337 | 4.97 |
01:50 ET | 8359 | 4.975 |
01:51 ET | 300 | 4.975 |
01:53 ET | 2800 | 4.975 |
01:55 ET | 2579 | 4.975 |
01:57 ET | 350 | 4.975 |
02:00 ET | 8829 | 4.985 |
02:02 ET | 200 | 4.985 |
02:04 ET | 13337 | 4.995 |
02:06 ET | 615 | 4.995 |
02:08 ET | 650 | 4.995 |
02:09 ET | 1800 | 4.995 |
02:11 ET | 1650 | 4.99 |
02:13 ET | 100 | 4.9901 |
02:15 ET | 200 | 4.995 |
02:18 ET | 9900 | 4.995 |
02:20 ET | 700 | 4.995 |
02:22 ET | 300 | 4.995 |
02:24 ET | 211 | 4.99 |
02:26 ET | 200 | 4.995 |
02:27 ET | 611 | 5 |
02:29 ET | 1088 | 4.99 |
02:31 ET | 1712 | 4.995 |
02:33 ET | 2753 | 4.995 |
02:36 ET | 551 | 4.99 |
02:38 ET | 300 | 4.995 |
02:40 ET | 641 | 4.995 |
02:42 ET | 1300 | 4.995 |
02:44 ET | 1650 | 4.995 |
02:45 ET | 200 | 4.995 |
02:47 ET | 715 | 4.995 |
02:49 ET | 1500 | 4.99 |
02:51 ET | 100 | 4.995 |
02:54 ET | 861 | 4.995 |
02:56 ET | 900 | 4.995 |
02:58 ET | 1447 | 4.995 |
03:00 ET | 40718 | 5.005 |
03:02 ET | 9147 | 5.0199 |
03:03 ET | 1617 | 5.015 |
03:05 ET | 18477 | 5.005 |
03:07 ET | 60993 | 5.02 |
03:09 ET | 2518 | 5.03 |
03:12 ET | 7182 | 5.035 |
03:14 ET | 2900 | 5.035 |
03:16 ET | 1183 | 5.0302 |
03:18 ET | 3840 | 5.032 |
03:20 ET | 5100 | 5.0301 |
03:21 ET | 16664 | 5.025 |
03:23 ET | 1206 | 5.025 |
03:25 ET | 865 | 5.025 |
03:27 ET | 3395 | 5.025 |
03:30 ET | 30633 | 5.02 |
03:32 ET | 19847 | 5.005 |
03:34 ET | 800 | 5.005 |
03:36 ET | 12212 | 4.99 |
03:38 ET | 200 | 4.995 |
03:39 ET | 422 | 4.995 |
03:41 ET | 42118 | 5.01 |
03:43 ET | 15622 | 5.015 |
03:45 ET | 6429 | 5.01 |
03:48 ET | 15401 | 5.015 |
03:50 ET | 9469 | 5.01 |
03:52 ET | 8174 | 5 |
03:54 ET | 37595 | 5.015 |
03:56 ET | 20012 | 5.03 |
03:57 ET | 11959 | 5.03 |
03:59 ET | 48135 | 5.01 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Aurinia Pharmaceuticals Inc | 724.5M | -9.2x | --- |
Arcturus Therapeutics Holdings Inc | 908.9M | -29.2x | --- |
Adaptive Biotechnologies Corp | 465.7M | -2.1x | --- |
Travere Therapeutics Inc | 586.7M | -1.5x | --- |
Anika Therapeutics Inc | 371.9M | -4.5x | --- |
WAVE Life Sciences Ltd | 754.5M | -11.4x | --- |
Aurinia Pharmaceuticals Inc. is a Canada-based fully integrated biopharmaceutical company. The Company is focused on delivering therapies to treat targeted patient populations with a high unmet medical need that are impacted by autoimmune, kidney and rare diseases. The Company has developed LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis (LN) and continues to conduct pre-clinical, clinical, and regulatory activities to support the voclosporin development program. LUPKYNIS is a calcineurin inhibitor (CNI) immunosuppressant, that improves near and long-term outcomes in LN when used in combination with mycophenolate mofetil (MMF) and steroids. LUPKYNIS reduces cytokine activation and blocks interleukin IL-2 expression and T-cell mediated immune responses. Voclosporin, the active ingredient in LUPKYNIS, is made by a modification of a single amino acid of the cyclosporine molecule. Its product pipeline includes AUR200 and AUR300.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $724.5M |
---|---|
Revenue (TTM) | $175.5M |
Shares Outstanding | 144.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.36 |
EPS | $-0.55 |
Book Value | $2.63 |
P/E Ratio | -9.2x |
Price/Sales (TTM) | 4.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -52.24% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.